Jacobs Levy Equity Management’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-686,208
| Closed | -$436K | – | 1061 |
|
|
2025
Q1 | $436K | Sell |
686,208
-861,007
| -56% | -$547K | ﹤0.01% | 934 |
|
|
2024
Q4 | $1.59M | Buy |
1,547,215
+23,139
| +2% | +$23.8K | 0.01% | 643 |
|
|
2024
Q3 | $1.8M | Buy |
1,524,076
+16,359
| +1% | +$19.3K | 0.01% | 627 |
|
|
2024
Q2 | $1.84M | Buy |
1,507,717
+977,782
| +185% | +$1.19M | 0.01% | 616 |
|
|
2024
Q1 | $1.16M | Sell |
529,935
-261,486
| -33% | -$570K | 0.01% | 691 |
|
|
2023
Q4 | $1.23M | Sell |
791,421
-260,684
| -25% | -$404K | 0.01% | 683 |
|
|
2023
Q3 | $1.36M | Sell |
1,052,105
-569,304
| -35% | -$734K | 0.01% | 625 |
|
|
2023
Q2 | $2.79M | Sell |
1,621,409
-269,977
| -14% | -$464K | 0.02% | 511 |
|
|
2023
Q1 | $2.86M | Buy |
1,891,386
+1,229,494
| +186% | +$1.86M | 0.02% | 508 |
|
|
2022
Q4 | $1.06M | Sell |
661,892
-432,426
| -40% | -$692K | 0.01% | 672 |
|
|
2022
Q3 | $1.59M | Buy |
1,094,318
+197,869
| +22% | +$287K | 0.01% | 608 |
|
|
2022
Q2 | $1.64M | Sell |
896,449
-178,661
| -17% | -$327K | 0.01% | 646 |
|
|
2022
Q1 | $2.87M | Sell |
1,075,110
-163,801
| -13% | -$437K | 0.02% | 544 |
|
|
2021
Q4 | $5.36M | Sell |
1,238,911
-155,159
| -11% | -$672K | 0.04% | 413 |
|
|
2021
Q3 | $7.1M | Sell |
1,394,070
-19,797
| -1% | -$101K | 0.05% | 363 |
|
|
2021
Q2 | $8.95M | Buy |
1,413,867
+816,469
| +137% | +$5.17M | 0.06% | 323 |
|
|
2021
Q1 | $4.62M | Sell |
597,398
-6,822
| -1% | -$52.7K | 0.04% | 429 |
|
|
2020
Q4 | $3.96M | Sell |
604,220
-10,502
| -2% | -$68.8K | 0.03% | 438 |
|
|
2020
Q3 | $4.09M | Buy |
614,722
+191,180
| +45% | +$1.27M | 0.04% | 386 |
|
|
2020
Q2 | $3.53M | Buy |
423,542
+180,530
| +74% | +$1.5M | 0.04% | 414 |
|
|
2020
Q1 | $1.86M | Buy |
243,012
+21,953
| +10% | +$168K | 0.02% | 490 |
|
|
2019
Q4 | $1.84M | Buy |
221,059
+137,408
| +164% | +$1.14M | 0.02% | 559 |
|
|
2019
Q3 | $617K | Buy |
83,651
+10,500
| +14% | +$77.4K | 0.01% | 691 |
|
|
2019
Q2 | $821K | Buy |
73,151
+2,350
| +3% | +$26.4K | 0.01% | 674 |
|
|
2019
Q1 | $761K | Buy |
70,801
+39,500
| +126% | +$425K | 0.01% | 714 |
|
|
2018
Q4 | $473K | Hold |
31,301
| – | – | 0.01% | 741 |
|
|
2018
Q3 | $579K | Sell |
31,301
-3,080
| -9% | -$57K | 0.01% | 748 |
|
|
2018
Q2 | $786K | Buy |
34,381
+10,780
| +46% | +$246K | 0.01% | 715 |
|
|
2018
Q1 | $671K | Sell |
23,601
-8,100
| -26% | -$230K | 0.01% | 725 |
|
|
2017
Q4 | $669K | Buy |
31,701
+19,451
| +159% | +$410K | 0.01% | 696 |
|
|
2017
Q3 | $223K | Buy |
+12,250
| New | +$223K | ﹤0.01% | 839 |
|